Hernia Management in Cirrhosis: Risk Assessment, Operative Approach, and Perioperative Care

J Surg Res. 2019 Mar:235:1-7. doi: 10.1016/j.jss.2018.09.052. Epub 2018 Oct 23.

Abstract

Background: The rising incidence of liver disease has complicated the management of common surgical pathologies. Hernias, in particular, are problematic given the shortage of high-quality data and differing expert opinions. We aim to provide a narrative review of hernia management in cirrhosis as a first step toward developing evidence-based recommendations for the care of these patients.

Materials and methods: A literature review using separate search strings was conducted for PubMed and Cochrane Central Register of Controlled Trials databases. Review articles, conference abstracts, randomized clinical trials, and observational studies were included. Articles without a focus on patients with end-stage liver disease were excluded. Manuscripts were selected based on relevance to perioperative risk assessment, medical optimization, surgical decision-making, and considerations of hernia repair in patients with cirrhosis.

Results: The existing literature is varied with regard to focus and quality of data. Of the 4516 articles identified, 51 full-text articles were selected for review. In general, there is evidence to suggest that individuals with compensated cirrhosis may successfully undergo and benefit from hernia repair. Patients at high risk for decompensated cirrhosis may be best served by nonoperative management.

Conclusions: Carefully selected patients with cirrhosis may proceed with herniorrhaphy. A multidisciplinary approach is essential to provide high-quality care and improve outcomes.

Keywords: Cirrhosis; End-stage liver disease; Hernia; Herniorrhaphy.

Publication types

  • Review

MeSH terms

  • End Stage Liver Disease / etiology
  • Hernia, Ventral / surgery
  • Herniorrhaphy / adverse effects*
  • Herniorrhaphy / methods*
  • Humans
  • Liver Cirrhosis / complications*
  • Perioperative Care*
  • Portasystemic Shunt, Transjugular Intrahepatic
  • Risk Assessment*